Home›Companies›Healthcare›Amplifi Vascular

Amplifi Vascular, Inc.

Develops a vein-enlarging device for patients preparing for hemodialysis access surgery.

Updated Nov 10, 2026·Latest SEC filing Jun 30, 2026·Suggest an edit

About Amplifi Vascular

Amplifi Vascular is a private company based in Prairie Village, Kansas, incorporated in 2023 in Delaware. It has reported $6,768,278 raised in two offerings on Form D since August 2023. Its chief executive is Sean Morris.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 21, 2024Nov 27, 2024amended Jun 30, 2026$5,960,278of $12.0M target59$101KDebt, OptionsRule 506(b)Form D/A ↗2 earlier filings
Jul 28, 2023Aug 21, 2023amended Jun 25, 2024$808,000of $8.0M target6$134KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$6,768,278

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Amplifi Vascular's Form D filed Jun 30, 2026.

Nathaniel Hagedorn
Nathaniel Hagedorn
Board of Directors
JS
Steve Braun
Steve Braun
Board of Directors
Sean Morris
Sean Morris
President and CEO, director
Also a director at Euphrates Vascular.

Sources

  1. SECAmplifi Vascular, Inc. Form D/A, filed Mar 26, 2026
  2. SECAmplifi Vascular, Inc. Form D, filed Nov 27, 2024
  3. SECAmplifi Vascular, Inc. Form D, filed Aug 21, 2023
  4. SECAmplifi Vascular, Inc. filing history
  5. CompanyAmplifi Vascular team
  6. PressAmplifi Vascular study and financing announcement